Evidence map›Paper›PMID 40175685›Full record

ArticleScientific reports2025

Optimal age for screening lumbar osteoporosis in celiac disease.

Azita Ganji, Sara Samadi, Masoumeh Sadeghi, Nikta Baniasadi, Vahid Ghavami, Reza Ganji

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Azita GanjiDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Ganjia@mums.ac.ir.ORCID http://orcid.org/0009-0007-2458-4046
Sara SamadiDepartment of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Masoumeh SadeghiDepartment of Epidemiology, Faculty of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
Nikta BaniasadiDepartment of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Vahid GhavamiDepartment of Biostatistics, School of public Health, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza GanjiDepartment of Orthopedic surgery, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Funding

Mashhad University of Medical Sciences 931686
6 · The paper itself

Abstract

Osteoporosis is a common and important predictor of poor outcomes in celiac disease (CD), which puts many patients at risk of further fractures. Our objective was to evaluate the stratification of osteoporosis odds in CD patients based on their age, aiming to determine the optimal timing for initiating osteoporosis screening in this population.This cross-sectional study was performed on adult CD patients who were referred to the Celiac Clinic Center between 2015 and 2020. The exclusion criteria included individuals with endocrine disorders, corticosteroid use, smoking habit, post-menopausal women, and patients younger than 25 years old. Intestinal pathology, bone mineral density (BMD), TGA-IgA serum level, and serum vitamin D were assessed at the time of diagnosis. A total of 199 CD patients, who underwent lumbar densitometry at the time of their diagnosis, were included in the study with a mean age of 39.14 ± 8.99 years old. Osteoporosis was observed in 23.6% patients, of whom 25.5% were men and 74.5% were women. The results revealed a notable disparity across the four age groups. After accounting for potential confounding factors in multivariate analysis in fully adjusted model, our findings demonstrated that individuals between the ages of 45 and 55 had 22% higher odds of developing lumbar osteoporosis (odds ratio, 1.22; 95% CI, 1.02-1.45) compared to those aged 25-35. Individuals with CD are at an increased risk of developing lumbar osteoporosis in middle age. Therefore, it is recommended to begin BMD screening at age 45 and beyond. This recommendation further emphasizes the importance of receiving appropriate treatment to prevent fractures and preserve bone health.

Indexed as

Celiac DiseaseLumbar VertebraeOsteoporosisAdultAge FactorsBone DensityCross-Sectional StudiesFemaleHumansMaleMass ScreeningMiddle AgedRisk FactorsAgeBMDBone mineral densityCeliac diseaseOsteoporosis

Identifiers

PMID40175685
PMCPMC11965413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.